BioLineRx News, BioLineRx Quote, BLRX Quote

BioLineRx (NQ:BLRX) Delayed: 3.36 +0.08 (2.44%)

Prev. Close

$3.28

Today 6M 1Y 5Y

Open

$3.25

52 Wk High

$1.63

52 Wk Low

$0.71

Day High

$3.36

Day Low

$3.18

P/E

N/A

EPS

$0.00

Volume

20,922

Friends, Peers and Foes (?): YP2 (more...)

ALERTS | RSS

May 27, 2026 07:38 AM BioLineRx (BLRX) Reports In-Line Q1 EPS
May 27, 2026 07:20 AM Form 6-K BioLineRx Ltd. For: May 27
May 27, 2026 07:00 AM BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 22, 2026 07:01 AM BioLineRx and Hemispherian to present GLIX1 data at ASCO 2026
May 22, 2026 07:00 AM Form 6-K BioLineRx Ltd. For: May 22
May 22, 2026 07:00 AM BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 20, 2026 07:01 AM BioLineRx to Report First Quarter 2026 Results on May 27, 2026
May 19, 2026 07:07 AM Form 6-K BioLineRx Ltd. For: May 19
May 19, 2026 07:02 AM BioLineRx reports positive preclinical data for GLIX1 in brain cancer
May 19, 2026 07:00 AM BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Pat

Entities mentioned with BLRX

View All Entities